Objective:To describe the infection control preparedness measures undertaken for coronavirus
disease (COVID-19) due to SARS-CoV-2 (previously known as 2019 novel coronavirus) …

The SARS-CoV-2 pandemic poses the greatest global public health challenge in a century.
Neutralizing antibody is a correlate of protection and data on kinetics of virus neutralizing …

Background The ongoing coronavirus disease (COVID-19) pandemic has major impacts on
health systems, the economy and society. Assessing infection attack rates in the population …

Background High-flow nasal cannula (HFNC) is an emerging therapy for respiratory failure
but the extent of exhaled air dispersion during treatment is unknown. We examined exhaled …

We investigated 68 respiratory specimens from 35 coronavirus disease patients in Hong
Kong, of whom 32 had mild disease. We found that severe acute respiratory syndrome …

The SARS-CoV-2 virus emerged in December 2019 and has caused a worldwide pandemic
due to the lack of any pre-existing immunity. Accurate serology testing is urgently needed to …

Human parvovirus 4 (PARV4), a recently discovered parvovirus found exclusively in human
plasma and liver tissue, was considered phylogenetically distinct from other parvoviruses. …

SARS-CoV-2 infection of children leads to a mild illness and the immunological differences
with adults are unclear. Here, we report SARS-CoV-2 specific T cell responses in infected …

… OTY Tsang, FHKCP, FHKAM (Medicine) … Vivien WM Chuang TY Wong YH Leung Edmond
SK Ma YL Law Owen TY Tsang KM Chan Iris HL Tsang TL Que Raymond WH Yung SH Liu …

Surrogate neutralization assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
that can be done without biosafety level 3 containment and in multiple species are …